Evidence of Plasmodium falciparum malaria resistan...[BMJ. 2003]

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: BMJ. 2003 Mar 22;326(7390):628-9. Links

Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports.

Färnert A, Lindberg J, Gil P, Swedberg G, Berqvist Y, Thapar MM, Lindegårdh N, Berezcky S, Björkman A.

Department of Medicine, Division of Infectious Diseases, Karolinska Institute, Karolinska Hospital, S-171 76 Stockholm, Sweden. anna.farnert@medks.ki.se

PMID: 12649236 [PubMed - indexed for MEDLINE]

PMCID: PMC151974

Combination atovaquone and proguanil hydrochloride vs. halofantrine for treatment of acute Plasmodium falciparum malaria in children.
Pediatr Infect Dis J. 1999 May; 18(5):456-61.

[Pediatr Infect Dis J. 1999]
Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
Clin Infect Dis. 2002 Nov 1; 35(9):e92-5. Epub 2002 Oct 9.

[Clin Infect Dis. 2002]
Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.
Clin Infect Dis. 2003 Aug 1; 37(3):450-1. Epub 2003 Jul 18.

[Clin Infect Dis. 2003]
ReviewMalarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group.
Am J Trop Med Hyg. 1999 Apr; 60(4):533-41.

[Am J Trop Med Hyg. 1999]
ReviewAtovaquone/proguanil for the prophylaxis and treatment of malaria.
Expert Rev Anti Infect Ther. 2005 Dec; 3(6):849-61.

[Expert Rev Anti Infect Ther. 2005]
» See reviews... | » See all...

Cited by 10 PubMed Central articles

Distinction of Plasmodium falciparum recrudescence and re-infection by MSP2 genotyping: a caution about unstandardized classification criteria.
Rouse P, Mkulama MA, Thuma PE, Mharakurwa S. Malar J. 2008 Sep 23; 7:185. Epub 2008 Sep 23.

[Malar J. 2008]
First case of emergence of atovaquone-proguanil resistance in Plasmodium falciparum during treatment in a traveler in Comoros.
Savini H, Bogreau H, Bertaux L, Bouchiba H, Kraemer P, Parzy D, Garnotel E, Rogier C, Simon F, Pradines B. Antimicrob Agents Chemother. 2008 Jun; 52(6):2283-4. Epub 2008 Apr 14.

[Antimicrob Agents Chemother. 2008]
Plasmodium falciparum malaria and atovaquone-proguanil treatment failure.
Durand R, Prendki V, Cailhol J, Hubert V, Ralaimazava P, Massias L, Bouchaud O, Le Bras J. Emerg Infect Dis. 2008 Feb; 14(2):320-2.

[Emerg Infect Dis. 2008]
» See all...

Patient Drug Information

Atovaquone (Mepron® )
Atovaquone is used to treat Pneumocystis carinii pneumonia (PCP).
Source: AHFS Consumer Medication Information

Recent Activity

Clear Turn Off Turn On

Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochlor...Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show

Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports.

Related articles

Cited by 10 PubMed Central articles

Patient Drug Information

Recent Activity